CSL Behring BV
Address: Bijster 14
4817 HX Breda
Tel: +31 (0)85 111 96 00
CSL Behring is a global leader in the plasma protein biotherapeutics industry. We research, develop, manufacture and market biotherapies that are used to treat serious and rare conditions. Users of our therapies rely on them for their quality of life and, in many cases, for life itself.
Our commitment to saving lives and improving the quality of life for people with serious and rare conditions is evident in everything we do. Whether we are manufacturing and marketing safe and effective products or researching and developing innovative biotherapies, we are first and foremost focused on fulfilling our customers’ needs.
Products and services
CSL Behring is a specialty biotherapeutics company, serving people with rare and serious diseases around the globe for more than a century.
Biotherapies differ from conventional pharmaceuticals in that they treat diseases with products derived from human plasma or manufactured by recombinant technologies, while conventional pharmaceuticals derive their products from chemicals. Biotherapeutic proteins replace missing components in the blood.
CSL Behring develops, manufactures, and markets protein-based therapies in the Bleeding Disorders, Critical Care, Immunoglobulins, Pulmonary, and Wound Healing areas.